Compare · EVH vs RTO
EVH vs RTO
Side-by-side comparison of Evolent Health Inc (EVH) and Rentokil Initial plc (RTO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both EVH and RTO operate in Other Consumer Services (Consumer Discretionary), so they compete in similar markets.
- RTO is the larger of the two at $7.45B, about 14.2x EVH ($524.2M).
- Over the past year, EVH is down 44.9% and RTO is up 24.2% - RTO leads by 69.1 points.
- EVH has been more active in the news (10 items in the past 4 weeks vs 2 for RTO).
- EVH has more recent analyst coverage (19 ratings vs 12 for RTO).
- Company
- Evolent Health Inc
- Rentokil Initial plc
- Price
- $4.67+10.66%
- $29.54-0.59%
- Market cap
- $524.2M
- $7.45B
- 1M return
- +9.24%
- -12.21%
- 1Y return
- -44.90%
- +24.17%
- Industry
- Other Consumer Services
- Other Consumer Services
- Exchange
- NYSE
- NYSE
- IPO
- 2015
- 2022
- News (4w)
- 10
- 2
- Recent ratings
- 19
- 12
Evolent Health Inc
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates through two segments, Services and True Health. The Services segment provides value-based care services that include Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows and engages patients; population health performance that delivers patient-centric cost effective care; and delivery network alignments. This segment also offers specialty care management solutions that support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation, and specific market dynamics; and comprehensive health plan administrative services that helps providers assemble the complete infrastructure required to operate, manage, and capitalize on a variety of financial and administrative management services. The True Health segment operates a commercial health plan for small and large businesses in New Mexico. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Latest EVH
- Director Ajayi Toyin was granted 41,096 shares, increasing direct ownership by 121% to 75,170 units (SEC Form 4)
- Director Glass Russell Monroe was granted 41,096 shares, increasing direct ownership by 113% to 77,347 units (SEC Form 4)
- Director Grua Peter J was granted 41,096 shares, increasing direct ownership by 187% to 63,075 units (SEC Form 4)
- Director Guertin Shawn M was granted 41,096 shares, increasing direct ownership by 187% to 63,075 units (SEC Form 4)
- Director Jelinek Richard M was granted 41,096 shares, increasing direct ownership by 113% to 77,533 units (SEC Form 4)
- Director Keck Kim was granted 41,096 shares, increasing direct ownership by 67% to 102,597 units (SEC Form 4)
- Director Smith Jill D. was granted 41,096 shares, increasing direct ownership by 178% to 64,233 units (SEC Form 4)
- Director Springstubb Brendan B was granted 41,096 shares, increasing direct ownership by 70% to 99,917 units (SEC Form 4)
- Director Barbarosh Craig A. was granted 41,096 shares, increasing direct ownership by 76% to 95,031 units (SEC Form 4)
- Evolent Health Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
Latest RTO
- SEC Form SD filed by Rentokil Initial plc
- SEC Form 6-K filed by Rentokil Initial plc
- SEC Form 6-K filed by Rentokil Initial plc
- SEC Form 6-K filed by Rentokil Initial plc
- Terminix Debuts New Podcast to Help Businesses Mitigate Operational Risk
- SEC Form 6-K filed by Rentokil Initial plc
- SEC Form 6-K filed by Rentokil Initial plc
- New York City Replaces Los Angeles as America's Most Mosquito‑Infested City, New Terminix Data Reveals
- SEC Form 6-K filed by Rentokil Initial plc
- SEC Form 6-K filed by Rentokil Initial plc